IMMUNE CHECKPOINT BLOCKADE ENHANCES EFFICACY OF NEOANTIGEN VACCINE

被引：1
|
作者：
不详
机构：
来源：
CANCER DISCOVERY | 2022年 / 12卷 / 06期
关键词：
D O I：
10.1158/2159-8290.CD-RW2022-065
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
Immune checkpoint blockade enhances the cytotoxic T-cell response primed by neoantigen vaccines. ©2022 American Association for Cancer Research.
引用
收藏
页码：1408 / 1408
页数：1
相关论文
共 50 条
  • [41] Prospects of immune checkpoint blockade and vaccine-based immunotherapy for glioblastoma
    Tietze, Stefanie
    Michen, Susanne
    Schackert, Gabriele
    Temme, Achim
    [J]. INNOVATIVE SURGICAL SCIENCES, 2021, 6 (01): : 35 - 48
  • [42] Immune checkpoint blockade and a neoepitope vaccine in a metastatic ovarian cancer model
    Ross, M. S.
    Tianzhou, M.
    Zhang, L.
    Tseng, G.
    Edwards, R. P.
    Vlad, A.
    [J]. GYNECOLOGIC ONCOLOGY, 2018, 149 : 83 - 84
  • [43] Combination Immune Treatment of a Highly Aggressive Orthotopic Murine Glioblastoma With Checkpoint Blockade Inhibition and Neoantigen Vaccination
    Liu, Connor
    Schaettler, Maximilian
    Bowman-Kirigin, Jay
    Bender, Diane
    Kobayashi, Dale K.
    Miller, Chris A.
    Johanns, Tanner M.
    Dunn, Gavin P.
    [J]. NEUROSURGERY, 2019, 66 : 44 - 45
  • [44] Evolution of neoantigen landscape during immune checkpoint blockade in non-small cell lung cancer
    Anagnostou, Valsamo
    Smith, Kellie N.
    Forde, Patrick M.
    Niknafs, Noushin
    Bhattacharya, Rohit
    White, James
    Adleff, Vilmos
    Phallen, Jillian
    Wali, Neha
    Hruban, Carolyn
    Guthrie, Violeta B.
    Rodgers, Kristen
    Naidoo, Jarushka
    Kang, Hyunseok
    Sharfman, William
    Georgiades, Christos
    Verde, Franco
    Illei, Peter
    Li, Qing Ka
    Gabrielson, Edward
    Brock, Malcolm
    Zahnow, Cynthia
    Baylin, Stephen B.
    Scharpf, Rob
    Brahmer, Julie R.
    Karchin, Rachel
    Pardoll, Drew M.
    Velculescu, Victor E.
    [J]. CANCER RESEARCH, 2017, 77
  • [45] Evolution of Neoantigen Landscape during Immune Checkpoint Blockade in Non-Small Cell Lung Cancer
    Anagnostou, Valsamo
    Smith, Kellie N.
    Forde, Patrick M.
    Niknafs, Noushin
    Bhattacharya, Rohit
    White, James
    Zhang, Theresa
    Adleff, Vilmos
    Phallen, Jillian
    Wali, Neha
    Hruban, Carolyn
    Guthrie, Violeta B.
    Rodgers, Kristen
    Naidoo, Jarushka
    Kang, Hyunseok
    Sharfman, William
    Georgiades, Christos
    Verde, Franco
    Illei, Peter
    Li, Qing Kay
    Gabrielson, Edward
    Brock, Malcolm V.
    Zahnow, Cynthia A.
    Baylin, Stephen B.
    Scharpf, Robert B.
    Brahmer, Julie R.
    Karchin, Rachel
    Pardoll, Drew M.
    Velculescu, Victor E.
    [J]. CANCER DISCOVERY, 2017, 7 (03) : 264 - 276
  • [46] Personalized targeted circulating tumor DNA (ctDNA) and T-cell responses after combined neoantigen vaccine and immune checkpoint blockade in ovarian cancer
    Sellars, MacLean C.
    Porter, Rebecca
    Liu, Ruolin
    Howard, Alexis A.
    Xiong, Kan
    Crnjac, Andela
    Tayob, Nabihah
    Keskin, Derin
    Adalsteinsson, Vicktor
    Wu, Catherine
    Konstantinopoulos, Panagiotis
    [J]. CANCER RESEARCH, 2024, 84 (05)
  • [47] Targeting β-catenin enhances immune checkpoint inhibition efficacy in osteosarcoma
    Nakahata, Kengo
    Nirala, Bikesh K.
    Shuck, Ryan L.
    Kurenbekova, Lyazat
    Yustein, Jason T.
    [J]. CANCER SCIENCE, 2022, 113 : 1622 - 1622
  • [48] Immuno-synergy? Neoantigen vaccines and checkpoint blockade in glioblastoma
    Woroniecka, Karolina
    Fecci, Peter E.
    [J]. NEURO-ONCOLOGY, 2020, 22 (09) : 1233 - 1234
  • [49] Targeting β-Catenin Enhances Immune Checkpoint Inhibition Efficacy in Osteosarcoma
    Nakahata, K.
    Nirala, B.
    Kurenbekova, L.
    Shuck, R.
    Yustein, J.
    [J]. PEDIATRIC BLOOD & CANCER, 2021, 68 : S250 - S250
  • [50] Immune-Checkpoint Blockade Enhances 225Ac-PSMA617 Efficacy in a Mouse Model of Prostate Cancer
    Czernin, Johannes
    Current, Kyle
    Mona, Christine E.
    Nyiranshuti, Lea
    Hikmat, Firas
    Radu, Caius G.
    Luckerath, Katharina
    [J]. JOURNAL OF NUCLEAR MEDICINE, 2021, 62 (02) : 228 - 231
12345